A POLST order goes beyond what a DNR can cover: it allows you to set your preferences for treatments such as nutrition, pain medicine, and antibiotics at the end of life, and it applies both inside and outside the hospital. However, it’s not without its drawbacks. Ultimately, it’s safest to draw up not only a POLST, but other types of tried-and-true directives, to ensure you get the end-of-life care you want.
A recent study of nearly 3,000 patients who had an overdose during long-term opioid treatment found that more than 90% of these patients continued to receive opioids — even after their overdose. Poor communication between emergency rooms and prescribing doctors is likely the culprit. What’s more, doctors receive little training in recognizing patients at high risk for overdose, or in treating addiction when they do spot it. An important strategy to address the current opioid crisis is to improve how doctors are educated about opioids.
There’s almost always something we can do to improve our health and well-being — even at the end of our lives. Palliative care is designed to improve the quality of life for people with life-threatening illnesses and their families by keeping a person comfortable and making sure his or her values and preferences guide the medical team’s actions. For this reason, good communication with your care team — and your loved ones — is essential, even before you or a loved one has developed a serious illness.
A recent summary paper published in The New England Journal of Medicine outlines where the Affordable Care Act (ACA) has succeeded and where it has fallen short. Although health care is now more accessible and affordable than before, many still lack coverage, and the available plans have some drawbacks. Rather than expanding insurance coverage, it will take a culture shift in how we provide care to truly improve the health of our nation.
Last year, only months after announcing that he had an aggressive form of melanoma, former President Carter declared that he was cancer free — thanks at least in part to a recently approved immunotherapy drug. Immunotherapy is a type of targeted therapy that helps boost the body’s own immune response to cancer. It does so while sparing healthy cells, thus minimizing side effects.
Retail health clinics are popping up everywhere, from drugstores and supermarkets to large retailers like Target and Walmart. Staffed by nurse practitioners or physician assistants, retail health clinics can be a great option, particularly if you’re younger and in generally good health. These clinics list their prices up-front and tend to be cheaper than a doctor’s visit. They’re convenient too: usually open extended hours, with no need for an appointment.
By the mid-20th century, most births took place in the hospital. But increasingly, some women are choosing to have their babies at home in an effort to avoid seemingly unnecessary interventions and find an alternative to hospital environments. We don’t have the best data to assess the safety of home birth. But a recent analysis offers insights that can help women make choices based on what they value the most.
Many people choose to own guns for sport or protection. But from a physician’s standpoint, guns create as many — or more — problems than they solve. Several studies have found that guns injure or kill far more people, often unintentionally, than they’re intended to protect.
Recently, several new drugs have been developed to treat hepatitis C, a serious viral infection that can cause severe liver damage if allowed to run unchecked. But these new drugs are incredibly expensive, and are unaffordable for many people who need them. Until drugs for hepatitis C (and other high-cost drugs) are priced at affordable levels, many people will be left unable to benefit from modern advances in drug therapy.
Fewer men are being given PSA tests to screen for prostate cancer. As screening rates have fallen, so have the number of prostate cancer diagnoses. This probably also means that fewer men are receiving potentially unnecessary treatment, with its attendant negative side effects. At the same time, it isn’t yet clear whether that comes at the cost of more aggressive cancers being caught at an incurable stage. Better screening tests may make the difference in helping strike the right balance between limiting harm and preventing prostate cancer deaths.